DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
49	全身性エリテマトーデス	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00987831 (ClinicalTrials.gov)	May 2009	30/9/2009	Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)	Biomarkers of Lupus Disease: Study of Biomarker Changes Before and After Treatment With Depomedrol and Background Medication Withdrawal in Patients With Mild to Moderate SLE Disease Activity	Systemic Lupus Erythematosus	Other: Group B SLE one blood donation;Other: Blood drawing only Group C;Drug: Group A SLE prospective study	Oklahoma Medical Research Foundation	Pfizer	Completed	14 Years	70 Years	All	158	Phase 1;Phase 2	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00987831
(ClinicalTrials.gov)

May 2009

30/9/2009

Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)

Biomarkers of Lupus Disease: Study of Biomarker Changes Before and After Treatment With Depomedrol and Background Medication Withdrawal in Patients With Mild to Moderate SLE Disease Activity

Systemic Lupus Erythematosus

Other: Group B SLE one blood donation;Other: Blood drawing only Group C;Drug: Group A SLE prospective study

Oklahoma Medical Research Foundation

Pfizer

Completed

14 Years

70 Years

All

158

Phase 1;Phase 2

United States